AcquisitionsMar 30, 2026, 05:04 AM
Thermo Fisher to Acquire Clario Holdings for $8.875 Billion
AI Summary
Thermo Fisher Scientific has announced a definitive agreement to acquire Clario Holdings, Inc. for approximately $8.875 billion in cash, plus potential deferred and contingent consideration. The acquisition is expected to close by mid-2026 and will expand Thermo Fisher's capabilities in the clinical trial technology and services space.
Key Highlights
- Thermo Fisher will acquire Clario for $8.875 billion in cash at closing.
- The deal includes an additional $125 million in deferred consideration and up to $400 million in contingent consideration.
- The acquisition is subject to customary closing conditions and regulatory approvals and is expected to be completed by the middle of 2026.
Price Impact
More from TMO